课题基金 / 基金详情

项目摘要

项目成果

Jay W Wright的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Advances in ovarian cancer research are limited by a failure to understand the etiology of the disease. In large part this is due to the absence of a natural model for epithelial ovarian cancerthe predominant form affecting womenand an inability for most animal systems to accurately reflect the normal biological factors that have been associated with ovarian cancer risk (namely age and ovarian function). As a result, the development of preventive strategies is limited by an inability to identify appropriate risk factors. We have utilized gene expression studies to identify changes in gene expression found in cultured ovarian cells from women with versus without a family history of the disease, and the rhesus model will be used to evaluate methods of altering gene expression in these "at risk" cells as a means to prevent ovarian cancer in women with a family history of the disease. In addition, we will use the nonhuman primate as a model to test whether the source of most ovarian cancers, the ovarian surface epithelium, may be eliminated using mild detergent to permanently reduce ovarian cancer risk. Current studies indicate that the surface epithelium does not regrow within 6 months of removal via deteregent.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NOVEL STRATEGIES FOR OVARIAN CANCER PREVENTION
BIOLOGY OF THE PRIMATE OVARIAN SURFACE EPITHELIUM
NOVEL STRATEGIES FOR OVARIAN CANCER PREVENTION
BIOLOGY OF THE PRIMATE OVARIAN SURFACE EPITHELIUM
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: